As of this week, consumers can get a generic version of Lipitor, the best-selling drug developed by Pfizer.
Heralding this fact, in the mainstream press as well as in the business press, are the kinds of praises and exultations one usually hears only on Oscar night.
Forbes.com’s Avik Roy, in his blog (The Apothecary) points to several of these http://www.forbes.com/sites/aroy/2011/11/30/lipitor-is-dead-long-live-lipitor/ .
One of the most interesting is certainly that by Paul Howard in “Medical Progress Today,” who offers a detailed accounting, and reminder, of how dramatically Lipitor has changed the nation’s cardiovascular landscape http://www.medicalprogresstoday.com/2011/11/the-end-of-the-age-of-lipitor.php.
Sign up for CT Mirror's free daily news summary.
Free to Read. Not Free to Produce.
The Connecticut Mirror is a nonprofit newsroom. 90% of our revenue comes from people like you. If you value our reporting please consider making a donation. You'll enjoy reading CT Mirror even more knowing you helped make it happen.YES, I'LL DONATE TODAY